Dr. Reichart has over 30 years of experience as a director of research and development, as well as a director of business development, sales and marketing in medical device start-up companies. Previously, Dr. Reichart held a number of senior positions at Bar-Ilan University’s Faculty of Life Sciences. She received her Ph.D. degree in biochemistry (cum laude) from Bar-Ilan University, Ramat Gan.
Dr. Selzer combines deep technological background, was a post-doctoral fellow at Penn State University, Pennsylvania, USA, and later a Senior Staff Scientist at the Weizmann Institute of Science in the department of Structural Biology. She was trained as a Patent Attorney at Webb &Co and worked as an in-house Patent Attorney at D-Pharm Ltd. and Quark Pharmaceuticals Ltd. She is a registered Israeli Patent Attorney and her practice areas include patent drafting and prosecution, patentability evaluations and freedom to operate opinions in the chemical, biological and pharmaceutical fields.
Dr. Selzer obtained her B.Sc. and M.Sc. degrees in Chemistry from the Hebrew University of Jerusalem and her Ph.D. in Biochemistry from the Weizmann Institute of Science.
Mr. Marcus has over 20 years of diversified senior managerial experience. Mr. Marcus has held senior financial positions with public and private biotechnology and medical device companies in Israel and the United States. He holds a B.A. in accounting and economics from Tel Aviv University, Israel.
Mr. Missulawin has over 7 years’ experience in accounting, auditing and finance of Hi-Tech and biotechnology companies. Before joining Polypid, Mr. Missulawin was an audit Senior at Ernst & Young Israel. He holds an MBA from Tel Aviv University in financial management, a BA in accounting and Economics from Bar-Ilan University, and is a certified public accountant in Israel.
Ms. Blum has over 16 years of diversified legal experience in local and global life science companies. She has vast knowledge in supporting all aspects of life science companies’ operations from the early stage of research and development through regulation and clinical trials until the final stage of commercial and distribution activities including leading complex negotiations and global transactions. Prior to joining PolyPid, she was a legal counsel in Gamida Healthcare Technologies Ltd, Savyon Diagnostics Ltd, Direx Medical Systems Ltd & Initia Ltd. Ms. Blum holds LL.B and LL.M degrees from Tel-Aviv University and she is a certified mediator.
Ms. Cohen has over 8 years of experience in private Hi-Tech companies, such as Ramdor, HiClass and Eldor, fulfilling key positions in general administration, human resource management and recruitment. Ms. Cohen was also an assistant marketing manager of Beit Berl College. She holds a B.A. degree in Sociology and Anthropology from the Tel Aviv University.
Dr. Nedvetzki has over 10 years’ experience in the biomedical R&D industry, primarily focused on the development of drugs and medical devices. Dr. Nedvetzki previously served as a Drug Development Manager at BioLineRx Ltd., where he headed development of numerous drug candidates, overseeing every aspect of drug discovery/development, through preclinical and early clinical planning and management. Dr. Nedvetzki earned his Ph.D. in immunology from the Hebrew University of Jerusalem and did his post-doctoral work at Imperial College in the UK.
Ms. Belotserkovsky has almost 20 years of experience in clinical trials including clinical trials management. Prior to joining PolyPid, Mrs. Belotserkovsky served as a Clinical Project Manager at Quintiles Ltd. She holds an M.Sc degree in Microbiology and MHA degree from Ben-Gurion University of the Negev.
Ms. Rubin has over 10 years of managerial experience in the pharmaceutical industry. Previously she held Quality Control, Analytical Compliance and other Quality managerial positions at TEVA Pharmaceuticals Ltd. Maria holds a B.Sc in Drug Chemistry from Bar-Ilan University and an MBA from the Open University in Israel.
Mr. Goldstein has 5 years’ experience in the biomedical R&D industry, focusing on project management of drugs and medical devices products development, Chemistry Manufacturing and Control (CMC) management, and assimilation of regulatory requirements. Prior to joining PolyPid, Mr. Goldstein served as an R&D engineer at Israel Defense Forces, responsible for management of various technological projects. Mr. Goldstein holds an M.Eng. Degree in Chemical and Bio-Chemical Engineering from the Technion Institute, Haifa, Israel.
Dr. Hagai is a seasoned Life Sciences executive with 20 years of successful track record in corporate Marketing & Business Development positions at various big pharma companies. Before joining Polypid, he served two years as VP Business development for Biotech Company at Aurum Ventures, the technology investment arm of Morris Kahn. Previously he held senior global positions at Teva Pharmaceuticals including Director of Global Strategic Marketing for innovative drugs in Multiple Sclerosis and Global head of Women’s Health Portfolio for EMIA-APAC region. Dr. Hagai holds a Pharm.D, is a Doctor in Clinical Biology and also holds a Master in Marketing (Paris V University).
Ms. Lev-ari has over 15 years of experience in the HR field. She has vast knowledge in all aspects of HR, with extensive expertise in the pharmaceutical and bio-tech industry. She has held senior positions in HR management, including building HR departments, strategic planning, recruitment, training, talent management, etc. She holds a B.A. degree in Behavioral Science and an M.B.A., both from the Rishon College of Management.
Ms. Gelber has over 20 years of experience in Clinical Trials, most of them in GlaxoSmithKline. Her roles included CRA and project management as well as leading the clinical operations and quality assurance, and being a line manager for the internal team and GSK’s clinical vendors. She holds a B.Sc degree in general biology from the Hebrew university in Jerusalem and an M.Sc in embryology and Teratology from Tel-Aviv University.